@@HeshNZ Not really. transactions occur across the development lifecycle from preclinical to marketed.
Risk v reward, more development and risk left = less $. However P2 to is hot here as both CEO and Chair stated thats where its at, and that they dont have resources or expertise to go further. And all see how good her-vaxx is. Imu is building data to build value. Remembering its novel pathbreaking tech, not a previously commercially proven method.
Besides, when are you finding the OBD? hopefully not in p2. In IMUs case it happened as per in P1.
Anyway, I wonder if eventually Her-vaxx OBD will be reformulated to 100ug (from 50ug) like PD1-vaxx.
Good luck all.
Why IMU is a multi multi bagger, page-6965
-
- There are more pages in this discussion • 20,422 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $342.1M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.7¢ | 4.5¢ | $906.2K | 19.67M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9543864 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 1266571 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |